跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,060 条关于
“castration-sensitive prostate cancer”
全部
96,060
临床试验
77,523
药物
2,267
机构
1,101
资讯
15,169
去年
AI Biomarker Predicts Survival and Treatment Response in Oligometastatic Prostate Cancer
去年
Ontario Expands Public Coverage of XTANDI for High-Risk Prostate Cancer Patients
6个月前
JAMP Pharma Group Launches Generic Enzalutamide for Prostate Cancer Treatment in Canada
去年
Biomarker-Driven Precision Medicine Transforms Treatment Landscape for Metastatic Castration-Sensitive Prostate Cancer
去年
AMPLITUDE Trial Shows Niraparib Combination Reduces Cancer Progression Risk by 37% in HRR-Mutant Metastatic Prostate Cancer
7个月前
ERLEADA Shows 51% Reduction in Death Risk Versus Darolutamide in Real-World Prostate Cancer Study
去年
FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer Based on ARANOTE Trial Results
去年
Apalutamide Demonstrates Superior Overall Survival Compared to Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer
去年
Zydus Lifesciences Gains USFDA Approval for Enzalutamide Formulations
去年
Apalutamide Demonstrates Superior Overall Survival Compared to Enzalutamide in mCSPC
第 1 页，共 1517 页
上一页
下一页
